Dupont Capital Management’s Integra LifeSciences IART Stock Holding History

Dupont Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,039	Closed	-$42.7K	–	389
2023 Q2	$42.7K	Sell	1,039 -1,798	-63%	-$86.5K	﹤0.01%	467
2023 Q1	$163K	Sell	2,837 -32,788	-92%	-$1.85M	0.01%	477
2022 Q4	$2M	Buy	35,625 +25,905	+267%	+$1.32M	0.09%	155
2022 Q3	$412K	Buy	+9,720	New	+$498K	0.02%	689
2021 Q4	–	Sell	-619	Closed	-$42K	–	1769
2021 Q3	$42K	Sell	619 -81	-12%	-$5.72K	﹤0.01%	1453
2021 Q2	$48K	Hold	700	–	–	﹤0.01%	1487
2021 Q1	$48K	Buy	+700	New	+$47.4K	﹤0.01%	1451
2020 Q3	–	Sell	-5,339	Closed	-$251K	–	1352
2020 Q2	$251K	Sell	5,339 -632	-11%	-$31.1K	0.01%	1039
2020 Q1	$267K	Sell	5,971 -3,261	-35%	-$171K	0.01%	912
2019 Q4	$538K	Sell	9,232 -1,069	-10%	-$63.6K	0.01%	809
2019 Q3	$619K	Sell	10,301 -6,461	-39%	-$385K	0.01%	696
2019 Q2	$936K	Buy	+16,762	New	+$863K	0.02%	566
2019 Q1	–	Sell	-6,923	Closed	-$312K	–	1209
2018 Q4	$312K	Buy	+6,923	New	+$380K	0.01%	918

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dupont Capital Management's IART Position: Q3 2023 in Review

Dupont Capital Management sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 1,039 shares — an estimated $42.7K sold.

Dupont Capital Management first reported a position in IART in Q4 2018 and held it in 13 quarters. The position peaked at $2M in Q4 2022. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

Dupont Capital Management reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
Dupont Capital Management sold 1,039 Integra LifeSciences shares in Q3 2023, an estimated $42.7K.
Dupont Capital Management first reported a position in Integra LifeSciences in Q4 2018 and held it in 13 quarters.
Dupont Capital Management's Integra LifeSciences position peaked at $2M in Q4 2022.
262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.